Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ACAD Stock Forecast, Price Targets, Chart, Dividends & Analysis

ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

16.87
 
USD
  
0.14
  
(0.84%)
Previous close: 16.73  Open: 16.51  Bid: 16.51  Ask: 16.83
52 week range    
14.15   
   31.93
Mkt Cap: 2,897 M  Avg Vol (90 Days): 1,477,286
Peers   
VNDA / 
BMY / 
PFE / 
JNJ / 
Last updated: Monday 23rd December 2024

Stock Rankings

55
MarketXLS Rank
55
Value
61
Technical
50
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BMY

0.0433117 B1557.33

JNJ

0.0343353 B24.14144.47

LLY

0.0078739 B85.26767.76

PFE

0.0653150 B33.6926.36

VNDA

0 B-254.78
Financials

ACAD Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-985000.0-1 M-1 M1 M1 M1 M4 M
Basic EPS from continuing operations-1.6-1.79-1.05-1.34-0.37
Basic EPS total-1.6-1.79-1.05-1.34-0.37
Basic weighted shares outstanding97 M101 M116 M123 M127 M147 M157 M160 M161683.0163819.0
Cost of sales3 M-3 M-9 M-12 M11 M21 M19 M10 M42 M
Depreciation-206000.0-647000.0-843000.0-1 M-1 M1 M2 M2 M2 M2 M
Depreciation unreconciled-206000.0
DepreciationAndAmortization-206000.0-647000.0-843000.0-1 M-1 M1 M2 M2 M2 M2 M
Diluted EPS total-0.95-1.63-2.34-2.36-1.94-1.6-1.79-1.05-1.34-0.37
Diluted normalized net income/share-1.34-0.37
Diluted weighted shares outstanding97 M101 M116 M123 M126 M147 M157 M160 M161683.0163819.0
Earnings from equity interest-281 M-168 M-213 M-51 M
EarningsFromEquityInterestNetOfTax-281 M-168 M-213 M-51 M
GainOnSaleOfPPE200000.03 M100000.0
GainOnSaleOfSecurity-2 M997000.0-997000.02 M4 M5 M
GeneralAndAdministrativeExpense33 M-3 M-3 M-4 M-4 M326 M389 M396 M369 M407 M
Gross operating profit120000.0-2 M13 M-13 M205 M328 M421 M465 M507 M685 M
Income before tax-92 M-164 M-270 M-288 M-244 M-234 M-281 M-168 M-213 M-51 M
Income taxes-426000.0330000.01 M1 M1 M876000.0611000.0351000.03 M10 M
Interest income755000.0499000.03 M4 M5 M11 M7 M591000.07 M17 M
MiscOtherSpecialCharges125 M-2 M997000.0-997000.02 M4 M5 M
Net income from total operations-92 M-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M-61 M
NetIncomeCommonStockholders-92 M-164 M-271 M-289 M-245 M-219 M-282 M-168 M-216 M-61 M
NetIncomeContinuousOperations-92 M-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M-61 M
NetIncomeDiscontinuousOperations40000.072000.0200000.0400000.02 M
NetNonOperatingInterestIncomeExpense755000.0499000.03 M4 M5 M11 M7 M591000.07 M17 M
Operating income-93 M-165 M-273 M-417 M-247 M-247 M-287 M-170 M-224 M-73 M
Operating income before depreciation (EBITDA)-92 M-166 M-268 M-286 M-242 M-235 M-284 M-167 M-222 M-68 M
OperatingExpense-93 M162 M286 M404 M453 M566 M708 M635 M731 M758 M
Other income net-125 M2 M-997000.0997000.0-2 M4 M5 M
OtherGandA33 M-3 M-3 M-4 M-4 M326 M389 M396 M369 M407 M
OtherOperatingExpenses-2 M-363000.0-361000.0-5 M-2 M-3 M-4 M-5 M-5 M
OtherWriteOff-100000.0
PromotionAndAdvertising-2 M-16 M-40 M38 M51 M2 M6 M9 M
ProvisionForGainLossOnDisposal40000.072000.0200000.0400000.02 M
RentAndLandingFees33 M-3 M-3 M-4 M-4 M
Research & development expense61 M74 M99 M149 M187 M240 M319 M239 M362 M352 M
ResearchExpense61 M74 M99 M149 M187 M240 M319 M239 M362 M352 M
Revenue per share-985000.0-1 M-1 M1 M1 M1 M4 M
SalariesAndWages-16 M-40 M-55 M-76 M-82 M600000.0300000.04 M
Selling Gen & administrative expense33 M88 M186 M255 M266 M326 M389 M396 M369 M407 M
SellingAndMarketingExpense88 M186 M255 M266 M38 M51 M2 M6 M9 M
SellingExpense88 M186 M255 M266 M
Total Income available for interest expense (EBIT)-92 M-164 M-270 M-288 M-244 M-234 M-287 M-170 M-224 M-73 M
Total common shares outstanding100 M113 M121 M125 M144 M155 M160 M161 M162 M165 M
Total net income-92 M-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M-61 M
Total ordinary shares166 M166 M166 M166 M166 M166 M166 M166 M166 M166 M
Total revenues120000.061000.017 M125 M224 M339 M442 M484 M517 M726 M
TotalExpenses-93 M165 M283 M395 M441 M577 M718 M646 M741 M800 M
TotalRevenue120000.061000.017 M125 M224 M339 M442 M484 M517 M726 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University